Concepedia

Aasim Sheikh

AS

Statistics

Publications

31

Citations

6.4K

H-Index

26

Active since

1999

Affiliations

GI Specialists of Georgia (United States)(Current)

Texas Liver Institute

The University of Texas Health Science Center at San Antonio

Clinical Research Institute

Inova Fairfax Hospital

Aasim Sheikh is an author at GI Specialists of Georgia (United States) specializing in medicine, hepatology, and hepatitis.

ORCID

Top concepts

Publications per year

1999–2024

31

Publications

31

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

, , +7

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

David R. Nelson, James N. Cooper, Jacob Lalezari et al. · Hepatology · 2015 · 688 citations · Full text

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

Eric Lawitz, Jay Lalezari, Tarek Hassanein et al. · The Lancet Infectious Diseases · 2013 · 328 citations

, , +10

1–5 of 31